ExpreS2ion will participate at key industry and investor events in March 2022
Hørsholm, Denmark, March 9, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and hold presentations at key industry and investor events in March. These include Aktiespararna’s Aktiedagen (March 14), the Swiss Nordic Bio event (March 23), and BIO-Europe Spring (March 28-31).By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-C001 HER2-cVLP breast cancer vaccine. More information on each